1. Home
  2. GCTK vs IMTE Comparison

GCTK vs IMTE Comparison

Compare GCTK & IMTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GCTK
  • IMTE
  • Stock Information
  • Founded
  • GCTK 2001
  • IMTE 2008
  • Country
  • GCTK United States
  • IMTE Malaysia
  • Employees
  • GCTK N/A
  • IMTE N/A
  • Industry
  • GCTK Medical/Dental Instruments
  • IMTE Consumer Electronics/Appliances
  • Sector
  • GCTK Health Care
  • IMTE Consumer Staples
  • Exchange
  • GCTK Nasdaq
  • IMTE Nasdaq
  • Market Cap
  • GCTK 5.1M
  • IMTE 5.3M
  • IPO Year
  • GCTK N/A
  • IMTE N/A
  • Fundamental
  • Price
  • GCTK $0.37
  • IMTE $1.26
  • Analyst Decision
  • GCTK
  • IMTE
  • Analyst Count
  • GCTK 0
  • IMTE 0
  • Target Price
  • GCTK N/A
  • IMTE N/A
  • AVG Volume (30 Days)
  • GCTK 4.1M
  • IMTE 6.4K
  • Earning Date
  • GCTK 03-27-2025
  • IMTE 03-04-2025
  • Dividend Yield
  • GCTK N/A
  • IMTE N/A
  • EPS Growth
  • GCTK N/A
  • IMTE N/A
  • EPS
  • GCTK N/A
  • IMTE N/A
  • Revenue
  • GCTK N/A
  • IMTE $123,337.00
  • Revenue This Year
  • GCTK N/A
  • IMTE N/A
  • Revenue Next Year
  • GCTK N/A
  • IMTE N/A
  • P/E Ratio
  • GCTK N/A
  • IMTE N/A
  • Revenue Growth
  • GCTK N/A
  • IMTE 4.75
  • 52 Week Low
  • GCTK $0.36
  • IMTE $1.06
  • 52 Week High
  • GCTK $99.00
  • IMTE $3.84
  • Technical
  • Relative Strength Index (RSI)
  • GCTK 26.08
  • IMTE 47.80
  • Support Level
  • GCTK $0.49
  • IMTE $1.21
  • Resistance Level
  • GCTK $0.68
  • IMTE $1.30
  • Average True Range (ATR)
  • GCTK 0.20
  • IMTE 0.07
  • MACD
  • GCTK 0.17
  • IMTE -0.00
  • Stochastic Oscillator
  • GCTK 0.71
  • IMTE 30.16

About GCTK GlucoTrack Inc.

GlucoTrack Inc is a medical device company. It focuses on the design, development, and commercialization of non-invasive glucose monitoring devices for use by people with diabetes and pre-diabetics. The company has developed a non-invasive glucose monitor, the GlucoTrack model DF-F glucose monitoring device, which is designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain, inconvenience, and difficulty of conventional spot finger stick devices. It has completed a feasibility study successfully demonstrating that a minimum two-year implant life is highly probable with the sensor design. They have also initiated an animal study with an initial prototype system that has thus far demonstrated a simple implant procedure and good functionality.

About IMTE Integrated Media Technology Limited

Integrated Media Technology Ltd is engaged in the development, sale, and distribution of autostereoscopic 3D display, 3D conversion equipment, and software, development, and sale of 3D autostereoscopic technology, and the provision of 3D consultancy services. It operates through the following segments: the sale of electronic glass, sales of air-filter products, sales of Halal products, NFT, corporate, provision of consultancy and provision of new energy products and solutions.

Share on Social Networks: